Imaging Malignant Gliomas with 99mTc-MIBI Brain Single-Photon Emission Computed Tomography

Abstract

In order to keep subscribers up-to-date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of contrast media and molecular imaging. Each bibliography is divided into 15 sections: 1 Reviews; 2 General; Contrast Agents: 3 Chemistry; 4 Technique; 5 Experimental; 6 Applications; Molecular Imaging: 7 Carbon; 8 Fluorine; 9 Gallium; 10 Hydrogen; 11 Indium; 12 Iodine; 13 Phosphorus; 14 Technetium; 15 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

Letter to the Editor

“…These new data should be considered in the design of future clinical studies of malignant glioma therapies as a way to quickly assess the therapies' efficiency. 1,3,4 Thank you for sharing these observations with your readers.…”

“…Moreover, MIBI uptake has been correlated with the grade of malignancy of gliomas. 4 • 99 mTc-MIBI brain SPECT may be helpful for evaluating the degree of tumor resection of malignant gliomas. 4 • 99 mTc-MIBI brain SPECT may help in establishing the prognosis of glioma patients at the end of radiation therapy, allowing for adaptations in patient care.…”

“…4 • 99 mTc-MIBI brain SPECT may be helpful for evaluating the degree of tumor resection of malignant gliomas. 4 • 99 mTc-MIBI brain SPECT may help in establishing the prognosis of glioma patients at the end of radiation therapy, allowing for adaptations in patient care. These new data should be considered in the design of future clinical studies of malignant glioma therapies as a way to quickly assess the therapies' efficiency.…”